An Act Regarding Mail Order Delivery of Prescription Drugs
Impact
The passage of LD2005 is expected to bring significant changes to state laws governing prescription drug delivery. By obligating pharmacy benefits managers to facilitate access to physical pharmacies during delays or issues with mail order medications, the bill seeks to enhance patient protections and promote more reliable access to necessary drugs. This could also set a precedent for how other regulations regarding pharmacy operations and patient services are structured in the future.
Summary
LD2005 seeks to enhance access to prescription medications by imposing requirements on pharmacy benefits managers regarding the delivery of mail-order prescriptions. Specifically, the bill mandates that if a prescription is delayed beyond one day past the expected delivery date, or if the received medication is deemed unusable, the pharmacy benefits manager must provide an alternative for the covered person to obtain their prescriptions at a physical network pharmacy. This provision aims to ensure patients do not face interruptions in their medication regime due to delivery issues.
Sentiment
Discussions surrounding LD2005 appear to be generally supportive, particularly from patient advocacy groups concerned with access to medications. While the legislation introduces new obligations for pharmacy benefits managers, those in favor contend that it is a necessary step towards ensuring that patients receive their prescriptions without unnecessary delays. However, some stakeholders from the pharmaceutical industry may express concerns about the operational implications and costs associated with compliance to these new requirements.
Contention
Notable points of contention include the potential financial impact on pharmacy benefits managers and how enforcement of the bill's provisions will be handled. Some critics may argue that the requirements could lead to increased costs for both pharmacies and the managers themselves, which could ultimately affect drug prices. Furthermore, there may be discussions regarding the practicality of implementing such regulations and the feasibility of measuring compliance consistently across various providers.
Amends the law on drug coverage to require insurance plans that provide coverage for prescription drugs to offer two options for prescription delivery.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.